retatrutide resting heart rate What Are the Risks of Taking Retatrutide? Side Effects, Safety, and Who Should Avoid It Retatrutide—A Game Changer in Obesity

6 In obesity without diabetes (a 72-week trial, ~3,127 participants), mean body-weight change reached roughly 7.5%, 8.4%, and 11.2% at 6, 12, and 36 mg versus about 2.1% with placebo on the treatment-regimen estimand, with the highest dose reaching approximately 12.4% (about 27 lb) on the efficacy estimand, accompanied by improvements in cardiometabolic risk markers

Patients with higher starting weights often respond well to tirzepatide dual mechanism

Pernicious Anemia: Parenteral vitamin B 12is the recommended treatment and will be required for the remainder of the patient's life

doi:10.1186/s12876-021-01660-5

After first use, pens may be stored either refrigerated or at room temperature (up to 86F/30C) for up to 56 days

SotkMClarkMSuurBEBrgesonE